Introduction
Over the last twenty years, important progress in molecular biology and recombinantt echnologiesh as led to new applications and areas of research in the field of protein NMR. The ability to produce, by recombinant technologies, pure, highly concentrated, and isotopically labeled samples hasa llowed both solution-and solid-state protein NMR to gain insight into the structural dynamics of many biomolecular systems with an atomic resolution. On the other hand, the very use of recombinant technology has led the fieldl argely to neglect the importance of post-translationalm odifications (PTMs),a ni ndispensable step in the maturationo fp roteins towards their functional forms that regulate the activity,l ocalization, stability, and physicochemical properties of proteins.P TMs have become especially relevant in the study of intrinsically disordered proteins (IDPs), which are attracting considerable interest among the biomolecular NMR community.I ndeed, IDPs are more susceptible to undergoing PTMs than folded proteins. [1] Because of the inherentf lexibility of these proteins, PTMs will have an important impact on their activity,c ellular localization,a nd interaction properties, by modulating their structural dynamics. [2] [3] [4] [5] [6] [7] [8] For example, N-terminal acetylation of a-synuclein [9] increases the helical propensity of the N-terminal segment [7] and enhances the affinity of a-synucleinf or calmodulin by af actor of 10. [10] Thus,n eglecting the impacto fP TMs on the general properties of proteinsw ill necessarily lead to an inaccurate descriptiono ft heir biochemical properties and ultimately of their physiological functions.
N-Myristoylation is the covalent attachment, catalyzed by the enzyme N-myristoylt ransferase (NMT),o fa14-carbon saturated fatty acid to the N-terminal glycine residue through an amide bond;i ne ukaryotic systems it usually occurs co-translationally.N -Myristoylation is av ery common PTM. By increasing the hydrophobicity of the modified protein, myristoylation is generally involved in membrane binding, targeting, and subcellular trafficking. [11] As such, many myristoylated proteins are involved in important physiological processes such as signaling pathways, oncogenesis, or viral replication. [12] Myristoylation can also be used to tune the activity of ap rotein through the effect known as the myristoyl-electrostatic switch. This effect consists of ac onformational change of the protein (usually triggered by the binding of al igand) that will expose the myristoyl group, previously sequesteredi nahydrophobic Incorporation of myristic acid onto the Nterminus of ap rotein is ac rucial modification that promotes membrane binding and correct localization of important components of signaling pathways. Recombinant expression of N-myristoylated proteins in Escherichia coli can be achieved by co-expressing yeast Nmyristoyltransferasea nd supplementing the growth medium with myristic acid. However,u ndesired incorporationo ft he 12-carbon fatty acid lauric acid can also occur (leadingt oh eterogeneous samples), especially when the available carbon sources are scarce, as it is the case in minimal medium for the expression of isotopically enriched samples. By applying this methodt ot he brain acids oluble protein 1a nd the 1-185 Nterminal region of c-Src, we showt he significant,a nd proteinspecific,d ifferences in the membrane bindingp roperties of lauroylated and myristoylated forms. We also presentarobust strategyf or obtaining lauryl-frees amples of myristoylated proteins in both rich and minimal media.
pocket. [13] This mechanism is at the core of the function of proteins such as the ADP ribosylation factor or recoverin. Finally, myristoylationa ppearst op lay an important role in apoptosis, because many proteolitic products of caspase 3a re myristoylated and subsequentlyup-or down-regulate apoptosis. [14] Myristoylationd oes not naturally occur in Escherichia coli, the most commonly used organismf or protein expression. Therefore, to obtain large amounts of isotopically labeled myristoylated proteins suitable for biomolecular NMR studies, two options are available. The first one is in vitro myristoylation, which requires, additionally to the protein of interest, purified NMT,myristoyl-CoA (the co-substrate of NMT), and an additional purification step to separate the myristoylated protein from the by-products.A na lternative approachi sb ased on the coexpression of the NMT and the substrate protein by use of abicistronic vector,i no rder to enablei n-cell modification. [15] However,L iu et al. reported that in minimal medium this procedure leads to mixtures of myristoylated and lauroylated forms of the recombinant protein. [16] However,t he factorsl eading to lauroylation remain unclear, andt he degree of lauroylation seems to be highly variable and inconsistent.I ndeed,o ther studies based on this myristoylation strategy (both in rich and in minimal media) didn ot report the formation of al auroylated form. [15, 17, 18] Here we confirm the observation of Liu et al. and demonstrate that myristoylated andl auroylated forms of the same protein exhibit significantly different lipid-binding properties, emphasizing the need to ensure the homogeneity of the attached fatty acid chains.C onsequently,w ea lso report an optimized strategy for obtaining pure myristoylated proteins.T his strategyh as been appliedt ot he production of two myristoylated proteins:b rain acid soluble protein 1( BASP1, also known as NAP-22a nd CAP-23) and the first two domains of c-Src: namely the Unique and SH3 domains (USH3). BASP1 is a 25 kDa intrinsically disordered protein highly abundanti nt he brain during development, involved in growth cone guidance and actin cytoskeleton organization [19] and interacting with holo-CaM specifically in its myristoylatedf orm. [20] c-Src is the leadingm ember of the Src family of non-receptor tyrosine kinases (SFKs), which are involved in many signaling pathways. Deregulation of these kinases, and in particularo fc -Src itself, affects cell migration, proliferation, ands urvival, all of which contributest oi ts oncogenic potential. The N-terminal (SH4) region of c-Src is co-translationally myristoylated at the N-terminal glycine unit. SH4 is abasic peptide situated at the beginning of the Unique Domain of Src, an intrinsically disordered domain not conserved among the Src family.M yristoylated SH4 is responsible for c-Src membrane anchoring, through concurrent hydrophobic and electrostatic interactions.
Results and Discussion
Expression of recombinant N-myristoylated protein in minimal medium leads to am ixture of N-myristoylated and N-lauroylated protein
We expressed recombinantly myristoylated BASP1 (MyrBASP1) by using the bicistrionic vector designed by Glück et al. [15] In order to measure the extent of myristoylationb ym ass spectrometry,w ef irst performed the expression in minimal mediums upplemented with unlabeled ( 14 N) ammonium chloride. The LC-MSa nalysis revealed the presence of two species differing in mass by 27 Da (Figure 1 ), thus suggesting that both N-myristoylated and N-lauroylated forms of BASP1 (differing in mass by 28 Da) had been produced,a sr eportedp reviously in the case of Arf1. [16] NMR analysis of the putative (later confirmed) myristoylated BASP reveals that the N-terminal acylation leads to ad isappearance of the 1 H, 15 NHSQC crosspeaks corresponding to the Nterminus (Figures S1 and S2 in the Supporting Information), probably due to micelle formation.
Further MS analysis of the two speciesb ym eanso fe lectron capture dissociation (ECD) and collisionallya ctivated dissociation (CAD) confirmed that the differencei nm assi s2 8.0302 AE 0.0035Da(CH 2 CH 2 ,calcd mass 28.0313 Da) and is due to myris- In order to explore the origin of the lauroylated form of BASP1 (LauBASP1), we measured the proportions of N-myristoylateda nd N-lauroylatedf orms of BASP1 in samples expressed under different conditions ( Figure 2 ). When expressed in richm edium( lysogeny broth,L B), BASP1 is only found in its N-myristoylated form ( Figure 2B ). When expressedi nm inimal mediumBASP1 is found in both its N-myristoylated and N-lauroylated forms,a nd the proportion of the N-lauroylated form increases with the length of the expression time ( Figure 2A and C). This suggests that under scarce conditions (minimal mediuma nd/or long expression times), myristoyl-CoAi sc onverted into lauroyl-CoA through b-oxidation and then used by the NMT (which is known to show weak discriminationb etween myristoyl-CoA and shorter acyl-CoA)t oa cylate BASP1. Expressing BASP1 in the presence of lauric acid only leads to the lauroylated form of BASP1 both in rich and in minimal medium( Figure2Da nd E). The same observations were made for USH3 (with ad ifferent expression strain of E. coli), regardless of whether it is expressedi nr ich or minimal medium (see below), thus suggesting that this problem is not specific to BASP1 but is insteadageneral problemt hat occurs especially in minimal medium but can also be observed in rich medium.
N-Myristoylated and N-lauroylatedf orms of the same proteinhave differentb iochemical properties
To test whether the biochemical properties of BASP1 and USH3 are affected by the length of the N-acyl chain, we per- www.chembiochem.org formed surfacep lasmonr esonance (SPR) experiments with immobilized liposomes. Because this method does not require isotopicl abeling, we obtained fully myristoylated or lauroylated samples by expression in rich mediums upplemented with the correspondingf atty acid (lauric or myristic acid). In the case of BASP1 (Figure 3A) , the binding to 1,2-dimyristoyl-snglycero-3-phosphocholine/l-a-phosphatidylserine (DMPC/PS) liposomes of LauBASP1 (K D = 86 nm)s hows an affinity reduced by afactor of 10 relative to MyrBASP1 (K D = 7.9 nm). Additionally,t he length of the acyl chain also seems to affect the dissociation behaviorb ecause MyrBASP1 dissociates from the liposome more slowly than LauBASP1 ( Figure 3A) .
In the case of myristoylated USH3 (MyrUSH3), the difference is even more pronounced. Lauroylated USH3 (LauUSH3) binding to DMPC/DMPG (2:1;D MPG = 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol)) liposomes is four times weakert han for MyrUSH3 ( Figure 3B ). Dissociation of the lauroylated form from the liposomes is also faster than for the myristoylated form.
Our SPR resultsc learly show that the length of the N-acyl chain influences biochemical properties. Therefore the two speciess hould be separated in order to obtain biochemically pure samples.
Production of pure N-myristoylated USH3
Our SPR results show that the lengths of the N-acyl chains influence the properties of N-acylated proteins. Therefore, it is necessary to obtain ap ure N-myristoylated sample for the pursuit of subsequent biochemical and NMR studies. As described above,t he lauroylated and myristoylated forms of BASP1 can be easily separated by RP-HPLC.H owever,t he use of organic solventi sn ot generallya pplicable to proteins containing folded domains, as in the case of USH3.
After protein expression, the soluble fraction of USH3 elutes from the size-exclusion column in the form of three different peaks ( Figure 4A ). SDS-PAGE ( Figure 4B )r eveals that peak 1 contain both USH3 and NMT,w hereas peak 2o nly contain USH3 (peak 3c ontains ad egraded form of the protein). Further MS analysis ( Figure 4C and D) showedt hat in peak 1 (whichc ontains both USH3 and NMT) USH3 is exclusively myristoylated whereas in peak 2U SH3 ( Figure 4E )i so nly found in its unmodified and lauroylated forms. Hence, it appearst hat MyrUSH3 co-purifies with NMT whereas LauUSH3 remains free of NMT due to the lower affinity of the enzyme for the shorter acyl chain forms.
This co-purification might be exploitable, because the purification of the complex could lead to af ully myristoylated sample. However, we were not able to dissociate the complex fully,e ither by chromatographic methods (such as ion exchange or hydrophobic separation) or by the use of myristoylated coenzyme Aa sacompetitor as suggested elsewhere. [21] Consequently,w ea pplieda nd refineda na lternative method originally proposed by Ha et al. [22] This exploits the strong affinity of the myristoylated protein towardsm embrane: as ignificant amount of myristoylated protein remains in the cell pellet www.chembiochem.org upon centrifugation, whereas mosto ft he NMT remains in the supernatant. This procedure relies on the resuspension and resolubilization of the membrane-bound protein, with use of Triton, before furtherp urification.T his procedure leads to am ixture of lauroylateda nd myristoylatedU SH3 that can be separated by size-exclusion chromatography.A sc an been seen from the size-exclusion profile ( Figure 5A ,r ed curve), the first peak corresponds to LauUSH3 ( Figure 5B )w hereas the second corresponds to MyrUSH3 (Figure5C). Intriguingly,w hen large amountso fL auUSH3 are produced ( Figure 5A ,g reen curve), at hird peak corresponding to am ixture of Myr and LauUSH3 is observed ( Figure 5D ). This last peak merges with the MyrUSH3 peak, compromising its purity.W hen the expression conditions are optimizedt om inimizet he productiono f LauUSH3( see below for ad etailed explanation), pure MyrUSH3 can easily be obtained( Figure 5A ,b lue curve). Thus, in order to be able to prepare pure myristoylatedp rotein efficiently, the expression protocols have to be optimized to minimize the presenceo fl auroylated forms before the purification. In addition, size separation of the two acylatedf orms is ap roperty of our particulars ystem and might noto ccur for other proteins, thus emphasizing the necessity to use conditions that ensure the presence of pure myristoylated proteins.
We hypothesized that lauroylCoA originates from b-oxidation of added myristic acid. This hypothesis would explain the observation that lauroylation increases under conditions of limited availability of carbon sources( minimal medium) or after extendede xpression (presumablya ssociated with nutrient depletion). Thus, one of the strategies that we tested was the addition of palmitic acid. NMT does not incorporate palmitoyl groups,b ut b-oxidation of palmitic acid would contribute to replenish the myristoylCoA pool.
Ta ble 1s ummarizes the effects of different expression factors on the relative amounts of MyrUSH3 and LauUSH3 obtained Rosettam yristic + palmitic acid 20 [b] 18 82 T7 myristic + palmitic acid 20 [b] 39 7
The relative amountso fm yristoylateda nd lauroylated USH3 were determined by integrating the elutionp eaks from size-exclusion chromatography performedo nt he mixtures obtained after the Triton wash purification procedure. www.chembiochem.org after the Triton wash procedure, nickel columnp urification, and size-exclusion chromatography.T he induction time appears to be the most important factor,b ecause longer expression times lead to greater amountso fl auroylated form. Nevertheless, some factors such as the expression strain or the addition of palmitic acidt ot he growth medium also have as ignificant impact on the myristoylation level. More specifically, expression in T7 cells yields lower lauroylation levels than expression in Rosetta cells. In rich medium, USH3i sf ound as am ixture of myristoylated and lauroylated forms even after short induction times (whereas under the same conditions BASP1 was fully myristoylated). However,a dding palmitic acid to the growth mediuml eads to almost pure myristoylated USH3. To sum up,t he set of bestc onditions consists of as hort induction time in the presence of both palmitic and myristic acid in the expression medium. Use of these conditions together with the Triton wash purification procedure leads to pure and homogeneous natural-abundance MyrUSH3 samples ( Figure 5A ,b lue curve, and E/F). However,e xpression in minimal media, required in order to produce isotopically labeled proteins,d id not provide pure MyrUSH3, presumably due to limited availability of carbon sources. This limitation was overcome by using the Marley method, which consists of generating cell mass in unlabeled rich media and subsequent transfer into labeled media just before induction. [23] In that case we were able to obtain sufficienta mounts of labeled proteins (95 %) to enableN MR measurement. Finally,t his protocol was also successfully used for the expression and purification of MyrBASP1, thus demonstrating the robustness of the method.
Conclusion
Myristoylation is an important post-translation modification generally involved in subcellular trafficking and membrane association.C orrect structural characterization of myristoylated proteins requires the production of their isotopically labeled forms. Co-expression of yeast NMT with the protein of interest in E. coli provides an efficient method but is complicated by the simultaneous formation of lauroylated andm yristoylated proteins.Although they are chemically similar, SPR experiments showedt hat the variation in chain length greatlya lters the lipid-binding properties. Therefore, as uitable method to obtain purelym yristoylated proteins in E. coli needs to be developed. We suggest here that the additiono fthe shorter acyl chain appearst ob ed ue to the conjunction of two factors: 1) the availability of as horter acyl-CoA generatedt hrough boxidation of the myristic acid that needs to be supplemented to the growth medium, and 2) the poor discrimination of the human NMT fort he shortera cyl-CoA. [24] On the basis of this hypothesis, we have shown that addition of palmitic acid, which is not incorporated into the protein by NMT but can resupply the MyrCoA pool, contributes, under some conditions, to minimize the formation of the lauroylated form.
The capacity to isolate lauroylateda nd myristoylated proteins from mixtures of the two is dependentu pon the physiochemicalp roperties of the proteins of interest. In the case of af ully disordered protein (BASP1), the two forms can be separated by RP-HPLC thanks to their different hydrophobicities.I n the case of ap artially or fully folded protein (USH3), we had to developamore sophisticated procedure based on 1) optimization of the expression conditions to minimize the formationo f LauUSH3,2 )use of the Triton wash purification protocol to obtain NMT-free myristoylated protein with al ow proportion of the lauroylated form, and 3) final purification by affinity and size-exclusion chromatography.I nterestingly, although both proteins have acyl moieties attached to ad isordered segment, their biochemical properties seem to be affected in different ways by the length of the acyl chain.I ti sknownthat myristoylation by itself is not enough for stable membrane attachment. Asecond bindinge vent is usually required. [11] Examples include electrostatic interactions, as econd aliphatic anchor, or additional contacts with amphipathic regions of the peptide backbone. Clearly,t he myristoyl chain plays as tronger role in lipid binding by USH3 than by BASP1.T his might be due to the proximity of the charged residues and the acyl chain in USH3, coupling the strength of the electrostatic interaction with the insertiono ft he acyl chain in the lipid bilayer,o rm ight be the result of an indirect effect caused by modulation of the SH4 and SH3 interactions by the presence of distinct fatty acid chains attachedt ot he SH4 domain. [25] Thus, if pure lauroylated and myristoylated forms of the same protein can be obtainedi ndependently or separated from mixtures,t he comparison of their lipid-binding properties provides additional insighti nto the processes involved in fattyacid-mediated lipid interactions.
To summarize, we provide evidence as to why the production of myristoylated proteins in E. coli by co-expressingN MT resultsi nah eterogeneously N-acylated sample. We have demonstrated that the different N-acylated forms have different biochemical properties and we have developed an expression/ purification protocol to generateahomogeneously N-myristoylatedsample. We expect these observations to be especially relevant for the conduct of NMR studies in which the homogeneity of the sample is essential.
Experimental Section
Protein expression and purification of myristoylated BASP1:E xpression was achieved with E. coli strain T7 Express (New England BioLabs) and the bicistronic vector pETDuet-1D6His_hNMT_ hBASP1_6His as already described. [15] Expression of BASP1 for the analysis of the protein by mass spectrometry was done either in rich medium (LB medium) or in M9 minimal medium with unlabeled ( ). In order to produce myristoylated protein, myristic acid was added to the growth medium at af inal concentration of 50 mm 10 min before induction. Fresh myristic acid stock solution was prepared as described elsewhere. [15] The cells were grown at 37 8Ct oa n OD 600 of 0. FT-ICR mass spectrometry:P rotein samples were desalted with Vivaspin 500 centrifugal concentrators (Sartorius, Germany,P ES membrane, MWCO 5000) as described previously [26] Briefly,aprotein solution ( % 10 mm,5 00 mL) was concentrated to 100 mL, and an aqueous ammonium acetate solution (100 mm,4 00 mL) was added. The process was repeated five times, followed by six cycles of concentration and dilution with H 2 O. For ESI (flow rate 1.5 mLmin À1 ), desalted protein was diluted to % 2 mm in H 2 O/CH 3 OH 1:1w ith acetic acid (1 %v ol) as additive. H 2 Ow as purified to 18 MW·cm at room temperature with aM illi-Q system (Millipore, Austria);C H 3 OH (Acros, Austria) was HPLC-grade. Experiments were performed with a7Tesla Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer equipped with an electrospray ionization source, ac ollision cell for CAD, and ah ollow dispenser cathode for ECD.
Myristoylated USH3 expression:U SH3 expression was performed in E. coli Rosetta (DE3)pLysS cells (Novagen) or T7 Express (New England BioLabs) cells and using the bicistronic vector pETDuet1D6His_hNMT_USH3_6His. The cells were grown at 37 8Ct oa n OD 600 of 0.8, and 10 min before induction with IPTG (final concentration 1mm,M elford), freshly prepared myristic and/or palmitic acid (Sigma) were added to the cell culture, at afinal concentration of 200 mm.F or the expression of isotopically labeled samples the protocol developed by Marley et al. was used: [23] cells were first grown in LB to an OD 600 of 0.4 and were then centrifuged at 1000 g and 4 8Cf or 20 min. The pellet was resuspended in half the volume of minimal medium containing ammonium chloride and glucose. After 20 min at 37 8C, myristic and palmitic acid were added as described above. The expression temperature was either 28 8C( for 5h)o r2 08C( for 20 h). The cells were pelleted by centrifugation at 3993 g at 4 8Cf or 30 min. The pellet was resuspended in lysis buffer [Tris·HCl (20 mm), NaCl (300 mm), imidazole (5 mm), pH 8],t ow hich protease inhibitors (protein inhibitor cocktail and phenylmethanesulfonyl fluoride (PMSF);1m m), both from Sigma) were added.
MyrUSH3 purification:T he resuspended pellet was sonicated on ice before centrifugation at 25 000 rpm for 45 min at 4 8C. The protein appeared to be distributed between the supernatant and the pellet, so two different purification methods were used. For the soluble fraction, the supernatant was applied to aN i-NTAc olumn (Qiagen) followed by size-exclusion chromatography in aS uperdex 75 column in sodium phosphate buffer (Na 3 PO 4 )[ NaP (50 mm), NaCl (150 mm), EDTA( 0.2 mm), pH 7.5].F or the insoluble fraction, the pellet was resuspended in lysis buffer containing Triton X-100 (1 %). The resuspended pellet was centrifuged again for 30 min at 75 600 g,a nd the procedure was repeated twice or three times. The supernatant from the Triton washes was purified by immobilized metal affinity chromatography as described above. If lauroylated species were present, they eluted from the size-exclusion chromatographic column at an apparent higher molecular weight than the myristoylated ones. This method enabled the two different acylated species to be separated and their respective amounts quantified. Ac omparison of various expression and purification protocols is presented in the Results section.
LC-MS:
The purities and identities of the products were established by UPLC coupled to MS [Acquity chromatograph with aB ioSuite pPhenyl column (1000RPC 2.0 75mm)] coupled to aL CT-Premier spectrometer (Waters corporation).
Liposome preparation:D MPC, DMPG, and PS were purchased from Avanti Polar Lipids, Inc. The lipids were dissolved in chloroform or,i nt he case of DMPG, in chloroform/methanol/H 2 O (65:35:8). Liposomes were prepared by mixing the appropriate amount of lipids in the solvent. The solvent was removed in ar otary evaporator,f ollowed by rehydration and vortexing at 40 8C with the buffer used for SPR analysis, with af inal lipid concentration of 1mm.T he different liposomes were prepared with aD MPC/DMPG ratio of 2:1o raDMPC/PS ratio of 4:1. Large unilamellar vesicles were mechanically extruded at 40 8Cb yu se of aT hermobarrel extruder (10 mL Thermobarrel extruder;L ipex Northerns Lipids Inc. Burnaby,C anada) with at least ten cycles of extrusion and use of ap olycarbonate filter (100 nm). To verify the appropriate size of the liposomes, the mean diameter was checked by dynamic light scattering (Zetasizer Nanoseries S, Malvern Instruments).
Surface plasmon resonance (SPR):S PR experiments with BASP1 were carried out with aB iacore 2000 instrument (Biacore, GE Healthcare) and SPR sensor chip (L1, Biacore, GE Healthcare). Liposomes were injected for 500 sa taf low rate of 5 mLmin
À1
.T he reference channel was coated with BSA by use of a2 00 si njection of BSA (1 mg mL
,S igma, fatty acid free) at af low rate of 10 mLmin
.P rotein binding experiments were performed at 50 mLmin
.T he interaction of MyrBASP1 or LauBASP1 with liposomes was followed by observing the SPR response when as olution of protein was injected for 100 s( association phase), followed by a3 00 sw ashing period (dissociation phase). MyrBASP1 binding to DMPC/PS liposomes was monitored by injections at concentrations ranging from 10 nm to 2.5 mm.L auBASP1 binding to DMPC/ PS liposomes was monitored by injections at concentrations ranging from 20 nm to 7.5 mm.A ll experiments were performed in the running buffer,w hich consisted of Na 3 PO 4 (20 mm), NaCl (50 mm), pH 7.4. The surface was regenerated with as eries of CHAPS (20 mm)/HCl (10 mm)/CHAPS (20 mm)p ulses, each pulse for 30 sa t 100 mLmin À1 .E ach experiment was started with freshly captured liposomes. Liposome coating was reproducible, with av ariation smaller than 4% between subsequent coatings, ensuring very reproducible protein binding curves.
SPR experiments with MyrUSH3 were performed in av ery similar fashion, with slight modifications. The SPR chip (a 2D carboxymethyldextran surface) was purchased from Xantec and modified by covalent attachment of phytosphingosine (TebuBio) to allow the capture of DMPC:DMPG (2:1) liposomes. Liposomes were injected at 10 mLmin À1 for 200 sb efore the protein binding experiment: MyrUSH3 or LauUSH3 was injected at 50 mLmin À1 for 60 s, and dissociation was allowed for 300 s. The running buffer was composed of Na 3 PO 4 (50 mm), NaCl (150 mm), EDTA( 0.2 mm,p H7.5). Liposome coating was reproducible, with av ariation of about 1% between the subsequent coatings, ensuring very reproducible protein binding curves. Data analysis was performed with the Biacore Biaevalution software.
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